Search results
Results from the WOW.Com Content Network
Here is whether Pfizer stock might be a buy today -- and why. Pfizer's pandemic boom (and bust) shouldn't haunt the stock much longer. Dividend investors will focus on Pfizer's current dividend ...
Similar to Pfizer, the company handily beat consensus earnings expectations this week, yet its stock plummeted 10% on the news that Merck is halting shipments to China of its cancer-preventing ...
Pfizer’s CEO stated that the company revamped its commercial strategy, brought in new leadership, and exceeded market share expectations. ... Price Action: PFE stock is down 1.49% at $26.40 at ...
The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of October 14, 2024. George Budwell has positions in Pfizer ...
Image source: Getty Images. 1. Coronavirus product growth shouldn't be a point of reference. Pfizer's revenue soared to a record level earlier in the pandemic, thanks to the company's market ...
Pfizer (NYSE: PFE) is an interesting healthcare company with excellent prospects for cash flow growth. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on ...